HPV discovered to be a new cause of skin cancer, report finds

Trisomy 18, a genetic condition long considered a death sentence for newborns, is seeing surprising breakthroughs. A handful of children are now surviving beyond infancy thanks to aggressive medical interventions, sheer determination from families, and a bit of luck. While most babies with the condition still don’t live long, these rare cases are challenging old assumptions and giving some parents precious extra time with their kids.

A simple scan called coronary artery calcium testing can spot dangerous plaque buildup in your heart's arteries—giving doctors a clearer picture of your risk for a heart attack. But despite its potential to save lives, this test isn't being used as much as it should be.

This piece rounds up the latest chatter in the health care sector, spotlighting big players like Novo Nordisk, GSK, and Sanofi. Think of it as a quick pulse check on how these companies are faring in the market—whether they’re riding high on new drug approvals, grappling with setbacks, or just holding steady. It’s the kind of insider scoop investors and industry watchers would want to skim over coffee.

Scientists have developed a groundbreaking implant designed to alleviate the chronic pain and inflammation caused by rheumatoid arthritis. Unlike traditional treatments that rely on frequent injections or oral meds, this tiny device works by delivering targeted therapy directly to affected joints, potentially reducing side effects and improving quality of life for millions. Early trials show promise, though larger studies are needed before it becomes widely available.

Editor’s Note: For people living with rheumatoid arthritis—a painful, often debilitating condition—this could be a game-changer. Current treatments can be hit-or-miss and come with hefty side effects. If this implant pans out, it might offer a more precise, long-term solution, giving patients a shot at less pain and more mobility. That’s a big deal in a field where progress has been slow.

Scientists have uncovered a fascinating twist in the evolutionary history of some of our favorite foods—turns out, potatoes and tomatoes share a much deeper connection than we thought. A new study reveals that these staples split from a common ancestor roughly nine million years ago, long before humans existed. The research sheds light on how these plants adapted over millennia, eventually becoming the wildly different (but equally delicious) crops we know today.

Editor’s Note: This isn’t just a fun fact for trivia night—it’s a glimpse into how nature tinkers with life over mind-boggling timescales. Understanding these ancient splits helps scientists piece together how plants evolve to survive, which could be crucial for breeding more resilient crops in the face of climate change. Plus, who doesn’t love imagining a primordial proto-potato-tomato hybrid?